XERESE: payments to doctors
Payments that named XERESE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Orapharma, A Division Of Bausch Health US, LLC?
Orapharma, A Division Of Bausch Health US, LLC reported the most payments naming XERESE. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $17K
- Providers
- 1,073
- Transactions
- 1,196
- Average per transaction
- $14
The per-transaction average — $14 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,073 providers the average total is $16, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Orapharma, A Division Of Bausch Health US, LLC | $13,646 | 81.2% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $2,715 | 16.1% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $311 | 1.9% |
| Bausch & Lomb Americas Inc. | $137 | 0.8% |
Other products from Orapharma, A Division Of Bausch Health US, LLC
The company that reported the most payments naming XERESE also reports against these.